Gubra A/S (CPH:GUBRA)

Denmark flag Denmark · Delayed Price · Currency is DKK
364.20
+9.20 (2.59%)
Apr 1, 2026, 4:59 PM CET
Market Cap5.95B -28.2%
Revenue (ttm)2.64B +892.2%
Net Income1.69B
EPS102.70
Shares Out16.33M
PE Ratio3.55
Forward PE151.75
Dividendn/a
Ex-Dividend Daten/a
Volume24,815
Average Volume32,205
Open360.00
Previous Close355.00
Day's Range355.20 - 368.40
52-Week Range293.00 - 571.00
Beta0.45
RSI46.21
Earnings DateAug 20, 2026

About Gubra

Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry; and various services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, bioinfor... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 300
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol GUBRA
Full Company Profile

Financial Performance

Financial Statements